ACM
OLMA icon

Aquatic Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Aquatic Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-111,186
Closed -$1.66M – 1602
2026
Q1 		$1.66M Buy
111,186
+95,872
+626% +$2.13M 0.05% 428
2025
Q4 		$383K Buy
+15,314
New +$273K 0.01% 815
2025
Q1 		– Sell
-31,565
Closed -$184K – 1538
2024
Q4 		$184K Buy
+31,565
New +$315K 0.01% 951

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Aquatic Capital Management's OLMA Position: Q2 2026 in Review

Aquatic Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 111,186 shares — an estimated $1.66M sold.

Aquatic Capital Management first reported a position in OLMA in Q4 2024 and held it in 3 quarters. The position peaked at $1.66M in Q1 2026. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Aquatic Capital Management reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 111,186 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.66M.
  • Aquatic Capital Management first reported a position in Olema Pharmaceuticals in Q4 2024 and held it in 3 quarters.
  • Aquatic Capital Management's Olema Pharmaceuticals position peaked at $1.66M in Q1 2026.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.